These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38987197)
1. Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus. Chang YP; Liu CH; Huang CB; Lee JY; Liu CJ; Su TH; Huang SC; Tseng TC; Chen PJ; Kao JH J Gastroenterol Hepatol; 2024 Jul; ():. PubMed ID: 38987197 [TBL] [Abstract][Full Text] [Related]
2. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. Saleh SA; Salama MM; Alhusseini MM; Mohamed GA World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761 [TBL] [Abstract][Full Text] [Related]
3. Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection. Liu CH; Liu CJ; Su TH; Huang SC; Tseng TC; Wu JH; Chen PJ; Kao JH Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359492 [TBL] [Abstract][Full Text] [Related]
4. Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct-acting antivirals. Chuaypen N; Chittmittrapap S; Avihingsanon A; Siripongsakun S; Wongpiyabovorn J; Tanpowpong N; Tanaka Y; Tangkijvanich P Hepatol Res; 2021 May; 51(5):528-537. PubMed ID: 33615687 [TBL] [Abstract][Full Text] [Related]
5. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection. Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients. Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717 [TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection. Ueda N; Kawaoka T; Imamura M; Aikata H; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Hayes CN; Yokozaki M; Chayama K BMC Gastroenterol; 2020 Sep; 20(1):314. PubMed ID: 32977741 [TBL] [Abstract][Full Text] [Related]
8. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection. Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755 [TBL] [Abstract][Full Text] [Related]
9. Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Suzuki T; Matsuura K; Nagura Y; Ogawa S; Fujiwara K; Nojiri S; Watanabe T; Kataoka H; Tanaka Y Hepatol Res; 2022 Nov; 52(11):919-927. PubMed ID: 35938598 [TBL] [Abstract][Full Text] [Related]
10. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection. Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C. Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups. Nah EH; Cho S; Kim S; Kim HS; Cho HI J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396 [TBL] [Abstract][Full Text] [Related]
13. [Change in Serum Levels of New Hepatic Fibrosis Marker "Mac-2 Binding Protein Glycosylation isomer (M2BPGi)" in Patients with Chronic Hepatitis C during the Treatment of Pegylated Interferon and Ribavirin]. Ishida H; Suetsugu A; Nakamura M; Tauchi R; Nakayama J; Katano Y; Shirakami Y; Furuta N; Ito H; Seishima M Rinsho Byori; 2015 Aug; 63(8):901-6. PubMed ID: 26638424 [TBL] [Abstract][Full Text] [Related]
14. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation. Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431 [TBL] [Abstract][Full Text] [Related]
15. Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients. Kikukawa K; Uchida-Kobayashi S; Tamori A; Yoshida K; Kotani K; Motoyama H; Kozuka R; Hagihara A; Fujii H; Morikawa H; Enomoto M; Murakami Y; Kawada N Ann Hepatol; 2020; 19(4):367-372. PubMed ID: 32444247 [TBL] [Abstract][Full Text] [Related]
17. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650 [TBL] [Abstract][Full Text] [Related]
18. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B. Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877 [TBL] [Abstract][Full Text] [Related]
19. Sequential Combination of FIB-4 Followed by M2BPGi Enhanced Diagnostic Performance for Advanced Hepatic Fibrosis in an Average Risk Population. Kim M; Jun DW; Park H; Kang BK; Sumida Y J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295166 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis. Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]